0
Oncolytics Biotech Inc. Banner Image

Oncolytics Biotech Inc. has reached its limit for free report views

Work for Oncolytics Biotech Inc.? Upgrade Your Profile and unlock all your annual reports.

Oncolytics Biotech Inc.

  • Ticker ONC
    Exchange TSX More
  • Industry Biotechnology More
  • Sector Healthcare More
Oncolytics Biotech Inc. Logo Image
  • 11-50 Employees
  • Based in Calgary, Alberta
Oncolytics Biotech Inc. is developing pelareorep, a safe and well-tolerated intravenously delivered immuno-oncolytic virus (IOV) that targets cancer through a unique mechanism of action with two components, selective tumor lysis and activation of the innate and adaptive immune systems, creating an inflamed phenotype to treat a variety of solid tumors and hematological malignancies.
Oncolytics Biotech Inc.

Most Recent Annual Report

Oncolytics Biotech Inc. MOST RECENT 2019 Annual Report

Report Locked. Oncolytics Biotech Inc. has reached its limit for free report views.

Older/Archived Annual Reports